Garza v. Davis-Director TDCJ-CID

CourtDistrict Court, S.D. Texas
DecidedSeptember 21, 2020
Docket4:18-cv-04387
StatusUnknown

This text of Garza v. Davis-Director TDCJ-CID (Garza v. Davis-Director TDCJ-CID) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Garza v. Davis-Director TDCJ-CID, (S.D. Tex. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT September 21, 2020 FOR THE SOUTHERN DISTRICT OF TEXAS David J. Bradley, Clerk HOUSTON DIVISION

DAVID GARZA, § # 01633521, § § Plaintiff, § v. § CIVIL ACTION NO. 4:18-4387 § LORIE DAVIS, et al., § § Defendants. §

MEMORANDUM OPINION AND ORDER Plaintiff David Garza, an inmate in the Texas Department of Criminal Justice– Correctional Institutions Division (“TDCJ”), brings this civil rights suit alleging that TDCJ officials denied him adequate medical care. Garza filed an initial complaint, an amended complaint, and a more definite statement (Dkt. 1; Dkt. 6; Dkt. 12). The Office of the Attorney General (“OAG”) as amicus curiae submitted a Martinez report and related exhibits (Dkt. 20, Dkt. 21),1 which the Court converted to a motion for summary judgment (Dkt. 28). Garza has responded (Dkt. 25, Dkt. 30), and the motion is ripe for decision. After reviewing the pleadings, the briefing and evidence submitted, the applicable law, and all matters of record, the Court concludes that summary judgment should be granted for Defendants and that Plaintiff’s claims should be dismissed with prejudice. In addition, Plaintiff’s motions for leave to amend (Dkt. 29, Dkt. 41), his motions to appoint counsel (Dkt. 36, Dkt. 37), and his motions for injunctive relief (Dkt.

1 See Martinez v. Aaron, 570 F.2d 317 (10th Cir. 1987); Cay v. Estelle, 789 F.2d 318, 323 & n. 4 (5th Cir.1986) (discussing the utility of a Martinez report). 27, Dkt. 33) will be denied. I. BACKGROUND Garza alleges that Defendants denied him adequate medical care from 2016-2018.

He states that he has a foot deformity that makes it painful to walk or stand for long periods and that he requires medical boots, which TDCJ provided only after a 9-year delay (Dkt. 12, at 1-2; Dkt. 25, at 3).2 He also alleges that he has had two major back surgeries and suffers serious back pain on some days (Dkt. 12, at 1). He states that his challenges are more difficult because he is legally blind and handicapped (id. at 2).

At all times relevant to this lawsuit, Garza has been incarcerated at the Estelle Unit. Garza sues four Defendants: Lorie Davis, the former director of TDCJ; Troy Selman, a former warden at the Estelle Unit; Betty Williams, M.D., a medical provider at the Estelle Unit; and Khari Mott, the business manager for the clinic at the Estelle Unit. He alleges that Williams did not adequately address his need for pain medications, and

that Mott interfered with his medical care and improperly handled some of his administrative grievances. He claims that Davis and Selman are responsible to provide adequate medical care to all inmates in their custody, including Garza. The OAG’s Martinez report attaches Garza’s relevant medical records, grievance records, and an affidavit from Glenda Adams, M.D., M.P.H., a physician consultant for

the University of Texas Medical Branch Correctional Managed Care. Adams’ affidavit,

2 Throughout this memorandum opinion, the Court’s citations to specific pages in the record refer to the pagination of docket entries on the Court’s electronic case-filing (“ECF”) system. prepared after reviewing Garza’s pleadings, grievances, and medical records, states that Garza has osteoarthritis, which causes chronic pain and is aggravated by obesity and age. She also states that he suffers from “keratoconus with markedly decreased visual acuity

but not complete blindness” (Dkt. 21-2, at 3). She avers that, since his arrival at TDCJ, Garza has been seen in chronic care clinics “at least annually,” and has been seen for acute problems “upon request” (id.). Garza is followed by the Brace and Limb Clinic and by Assistive Disability Services (“ADS”) (id. at 4). His health classification form (“HSM-18”) dated December 18, 2015, reflects medical restrictions including a lower

bunk assignment, a limitation to sedentary work assignments, and limits on lifting and other physical activity (id. at 3-4; id. at 22 (Exhibit 3)). Garza also has been issued medical passes for additional needs not covered by the HSM-18, including passes for contact lenses, compression stockings, an orthopedic cane, medical shoes, shower shoes, and a special diet (id. at 31-43 (Exhibit 5)). He has passes related to his disabilities,

including showering accommodations, a reading magnifier, a talking watch, a cane to identify him as visually impaired, and delivery of his meals (id.). Regarding Garza’s medications for his chronic pain, Adams avers that Garza has been supplied with acetaminophen; non-steroidal anti-inflammatory drugs (“NSAIDs”) such as naproxen; nortriptyline (Pamelor); and duloxetine (Cymbalta) (id. at 4).

Adams recounts that Garza had only one clinic encounter with Williams, which was on December 12, 2016 (id.; id. at 56-64 (Exhibit 8)). At the appointment with Williams, Garza complained that his new medical footwear, which he had received approximately two weeks prior, hurt his feet (id. at 61). He requested additional equipment and medication, as well as a medical “unassignment” to excuse him from work duties (id. at 61-62). Williams determined that Garza’s limitation to sedentary work was adequate for his medical needs, but facilitated his requests for medical

supplies. She also ordered pain medications for Garza, in particular, acetaminophen and a 30-day prescription for naproxen. Williams’ notations in the medical records reflect that she advised Garza against long-term use of naproxen and other NSAIDs due to an “increased risk of serious cardiovascular thrombotic events, Myocardial infarction and Stroke, which can be fatal,” as well as increased risk of serious gastrointestinal events or

kidney failure (id. at 62).3 Garza disputes Adams’ statements and claims that, although Adams “makes it sound like [he] has it easy,” it took him years of fighting for his passes before he got them (Dkt. 25, at 9). He also denies that he has been issued any medical restrictions, states that medical supplies referenced by Adams were ineffective or not received, and

alleges that his medical records have been improperly altered (id. at 9-10, 13). Regarding his medications, Garza states that, for a period of approximately three months at an unspecified time, a medical provider named Barber prescribed him naproxen, which apparently was more effective for pain relief (id. at 11; Dkt. 30, at 3).

3 Although Williams did not have additional clinic visits with Garza, she was involved in his medical care at other times and assisted other providers with his care. In August 2017, Williams ordered allergy medications and medical equipment (id. at 5; id. at 65-68 (Exhibit 9)); on December 24, 2017, she verbally authorized a renewal of his blood pressure medication (id. at 5-6; Dkt. 21-3, at 3 (Exhibit 10)); in April and May 2018, she facilitated his medication refills and clinic visits (Dkt. 21-2, at 6; Dkt. 21-3, at 8 (Exhibit 11); id. at 17 (Exhibit 12)); in August 2018, she provided verbal orders for treatment of a boil (Dkt. 21-2, at 7; Dkt. 21-3, at 33-34 (Exhibit 13); id. at 37-38 (Exhibit 14)); and in March 2019, she referred Garza to optometry (Dkt. 21-2, at 7; Dkt. 21-3, at 41 (Exhibit 15)). However, he appears to complain that the naproxen was not sufficiently renewed and that, in December 2016, Williams limited his prescription to 30 days. He disagrees with Williams’ opinion about the dangers associated with long-term use of naproxen and other

NSAIDs.4 Adams provides her professional opinion that Williams acted in good faith based on “the information available to her[,] including the FDA’s repeated warnings on the potential dangers of chronic NSAID use,” that she did not refuse to treat Garza’s chronic pain, and that the care Garza received was “well within the standard of care” (Dkt. 21-2,

at 7, 9).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
McCormick v. Stalder
105 F.3d 1059 (Fifth Circuit, 1997)
Burns v. Exxon Corporation
158 F.3d 336 (Fifth Circuit, 1998)
Hamilton v. Segue Software Inc.
232 F.3d 473 (Fifth Circuit, 2000)
Domino v. Texas Department of Criminal Justice
239 F.3d 752 (Fifth Circuit, 2001)
Townsend v. Moya
291 F.3d 859 (Fifth Circuit, 2002)
Malacara v. Garber
353 F.3d 393 (Fifth Circuit, 2003)
Geiger v. Jowers
404 F.3d 371 (Fifth Circuit, 2005)
Gobert v. Caldwell
463 F.3d 339 (Fifth Circuit, 2006)
Easter v. Powell
467 F.3d 459 (Fifth Circuit, 2006)
Baranowski v. Hart
486 F.3d 112 (Fifth Circuit, 2007)
Samford v. Dretke
562 F.3d 674 (Fifth Circuit, 2009)
Dillon v. Rogers
596 F.3d 260 (Fifth Circuit, 2010)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Rhodes v. Chapman
452 U.S. 337 (Supreme Court, 1981)
Neitzke v. Williams
490 U.S. 319 (Supreme Court, 1989)
Helling v. McKinney
509 U.S. 25 (Supreme Court, 1993)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Garza v. Davis-Director TDCJ-CID, Counsel Stack Legal Research, https://law.counselstack.com/opinion/garza-v-davis-director-tdcj-cid-txsd-2020.